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Background: Pregnancy is a state characterized by profound physiological hematological 
changes. However, hematological reference intervals being used in clinical practice in Ethiopia 
are derived from nonlocal general populations, despite the significant variations reported 
previously. The aim of this study was to determine the immunological and hematological 
reference intervals in healthy pregnancy among HIV-seronegative pregnant women in northwest 
Ethiopia.
Materials and methods: A total of 200 healthy, HIV-seronegative pregnant women were 
enrolled from February 2015 to June 2015 in a cross-sectional study setting at Gondar University 
Hospital. Sociodemographic and obstetric data were collected using a structured questionnaire. 
Blood samples collected from each participant were used to define the immunological and 
hematological parameters. The mean, median, and 95% interval values were calculated for 
the immunological and hematological parameters. P-value ,0.05 was considered statistically 
significant for all variables.
Results: This study found that there were changes in CD4+ T-cell count, platelet count, and 
hematocrit (HCT) values as pregnancy advances. The calculated combined reference intervals 
for the absolute CD4+ T-cell count and platelet count were 712.47–760.67 and 221.25–240.14, 
respectively. A progressive decline in the platelet count was observed as pregnancy advanced, with 
95% intervals of 224.53–253.21, 209.50–237.38, and 213.70–247.86 in the first, second, and third 
trimesters, respectively (P=0.27). There was a statistically significant increase in mean (±standard 
deviation [SD]) HCT with gestational age, being 39.18±6.70, 41.96±3.70, and 40.53±3.77 in the 
first, second, and third trimesters, respectively (P=0.03). The overall 95% interval for hemoglobin 
(HB) concentration was 12.99–13.36 g/dL, HCT 40.19%–41.49%, mean corpuscular volume 
(MCV) 93.33–94.63 fL, and mean corpuscular hemoglobin (MCH) 28.88–34.81 pg. Compared 
with the reference ranges derived from other studies, we found considerable variations in CD4+ 
T-cell count, HB, HCT, and MCV values.
Conclusion: The findings of this study highlight the differences in immunohematological profile 
among pregnant women and nonpregnant women from Ethiopia and other countries, in addition to 
suggesting the need for such establishment of local reference values for different populations.
Keywords: immunological parameter, hematological parameter, pregnant women, refer-
ence range, immunohematological reference intervals
Introduction
Hematological and immunological reference intervals play a critical role as clinical 
guides in the diagnosis or monitoring of several diseases as well as adverse reactions 
during clinical trials.1,2 These parameters have been reported to vary by age, sex, preg-
nancy, dietary patterns, genetic background, and geographical factors.3–5 For example, 
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Ethiopian populations have been reported to have high hemo-
globin (HB) and hematocrit (HCT) levels when compared to 
some African countries and Western populations.6,7 On the 
other hand, they have lower CD4+ T-cell counts and CD4+/
CD8+ T-cell ratios.7 The Clinical and Laboratory Standards 
Institute (CLSI) recommends that each laboratory establish 
its own reference intervals for proper interpretation of labora-
tory test results. However, many African countries are still 
relying on reference values obtained from textbooks based 
on nonlocal populations.
Immunohematological reference intervals among 
different segments of the Ethiopian population are poorly 
defined. Although few studies have been conducted in 
Ethiopia to determine the immunological as well as hema-
tological reference intervals for the general population, 
there is scarcity of data on reference intervals for pregnant 
women.6,7 Pregnancy is a state characterized by profound 
hematological changes, such as changes in HB concentra-
tion, platelet (PLT) count, as well as red blood cell (RBC) 
and white blood cell (WBC) counts.8–10 The use of reference 
intervals derived from general non-Ethiopian populations 
could lead to misinterpretation of the laboratory test results 
and may allow incorrect clinical care for this group of the 
population. Hence, it is mandatory to establish local immu-
nohematological reference intervals for pregnant women. 
This would be especially useful during antiretroviral therapy 
(ART) initiation and treatment follow-up of HIV-positive 
pregnant women. In addition, this study is of importance 
because an attempt to predict and/or improve pregnancy 
outcome during antenatal care are also dependent on immu-
nohematological indexes.
The aim of this study was to establish the immunological 
and hematological reference intervals of healthy and HIV-
seronegative pregnant women in Northwest Ethiopia. In addi-
tion, it compared the reference values obtained from this study 
with previously reported values from different countries.
Materials and methods
study settings, population, and period
In this study, 200 healthy HIV-negative pregnant women 
attending the antenatal clinic (ANC) were included. Only 
pregnant women with body mass indexes within the normal 
range were enrolled into the study. The study was conducted 
at the University of Gondar Teaching Hospital, Gondar, North-
west Ethiopia, in a cross-sectional setting. Gondar is located at 
737 km from the country’s capital Addis Ababa in the North 
Gondar zone of the Amhara regional state. The city has latitude 
and longitude of 12°03′61″ N and 37°02′81″ E, respectively 
and an elevation of 2,133 m above sea level. The study was 
conducted between February 2015 and June 2015.
Data collection
Sociodemographic and obstetric characteristics of the study 
participants were collected using a structured questionnaire. 
Variables such as age, marital status, educational status, 
occupation, gestational age, smoking habit, and alcohol use 
were collected.
laboratory methods
Approximately 4 mL of venous blood was collected from each 
study participant in the morning from 8:00 am to 11:00 am 
and processed within 3 hours of collection. Hematological 
parameters were determined by a Cell-Dyn® 1800 (Abbott 
Laboratories, Chicago, IL, USA) which was standardized 
against a 4C® Plus blood control. The immunological param-
eters were analyzed using the BD FACSCount™ system 
(Becton Dickinson, San Jose, CA, USA). The performance 
of the instruments was controlled by running control samples 
prior to the start of the test.
HIV infection was detected using rapid HIV-1/2 test 
kits as per the national algorithm for HIV testing. Briefly, 
whole-blood samples were screened for HIV using a KHB 
diagnostic kit (Shanghai Kehua Bio-engineering Co Ltd, 
China). Reactive samples were confirmed using Stat-Pak® 
(Chembio Diagnostics, Medford, NY, USA) and Uni-Gold™ 
kits (Trinity Biotech, Bray, Wicklow, Ireland) according to 
the national algorithm for HIV testing.
statistical analysis
Data were checked for completeness and entered using SPSS 
version 20 software (IBM Corporation, Armonk, NY, USA) 
for analysis. A descriptive analysis was used to summarize 
the sociodemographic and clinical characteristics of the study 
participants. Reference intervals were computed using the 
nonparametric method. The mean, median, and standard 
deviation (SD) values were calculated for each immuno-
hematological parameter. The 95th percentile reference 
intervals were determined. Analysis of variance (ANOVA) 
was used for any statistically significant difference in these 
parameters in relation to the age and trimesters of the study 
participants. P-values ,0.05 were considered statistically 
significant for all variables.
ethical considerations
Ethical clearance was obtained from the institutional ethi-
cal review board of the University of Gondar. A permission 
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letter was also obtained from the hospital’s clinical director 
to conduct the study. After explaining the objectives of the 
study, written informed consent was obtained from each 
study participant. In cases of participants who were unable 
to read and write, a finger print was obtained as a signature 
in presence of literate witnesses. The interviews with study 
participants were conducted with strict privacy, and their data 
were handled with assurance of confidentiality.
Results
Demographic and obstetric 
characteristics
A total of 200 pregnant women were enrolled in this study. 
The age range of the participants was 18–42 years. Seventy-
two (36%) participants were younger than 24 years, 111 
(55.5%) were between 25 and 33 years, and 17 (8.5%) were 
between 34 and 42 years. Almost all (99.5%) of the women 
were married, and 103 (51.5%) of them were multigravidae. 
In terms of their gestational age, 34.5% and 43% of the 
study participants were on their second and third trimesters, 
respectively. All of the participants reported no smoking and 
no alcohol use (Table 1).
Immunological parameters
The mean, median, and 95% reference values stratified by 
gestational age for absolute CD4+ T-cell count, percentage 
CD4+ T-cell count, lymphocytes and total WBC counts 
are summarized in Table 2. The overall mean (±SD) CD4+ 
T-cell count was 738±173, while the percentage CD4+ 
T-cell count was 39.53±6.82, mean lymphocytes count was 
2.20±0.53, and total WBC count was 9.24±2.52. In terms 
of their gestational age, the minimum mean (±SD) value for 
absolute CD4+ T-cell count (728±171) was observed among 
women in the second trimester of their pregnancy, whereas 
the maximum (758±218) was observed among the women 
in the first trimester of pregnancy. Percentage CD4+ T-cell 
counts (median) in the first, second, and third trimesters of 
the pregnant women were 38.82, 40.18, and 39.60, respec-
tively. The calculated combined reference intervals for total 
lymphocytes were 2.18–2.53, 1.96–2.22, and 2.11–2.33 in 
the first, second, and third trimesters, respectively.
Except for lymphocyte count, which was significantly 
lower among women at the second trimester (P,0.05), 
no significant difference between various WBC subset 
values was observed with the age and gestational age of the 
women (P.0.05).
Hematological parameters
Table 3 shows the mean values, medians, and 95th percentile 
reference intervals according to gestational age for different 
hematological parameters. The mean PLT and RBC counts 
of the study participants were 230.70±67.74 and 4.37±0.49, 
respectively. The overall mean value for HB concentration 
was 13.2±1.3 g/dL, HCT level was 40.8%±4.7%, MCV was 
93.98±4.64 fL, mean corpuscular hemoglobin (MCH) was 
30.36±2.41 pg, and mean corpuscular hemoglobin concentra-
tion (MCHC) was 32.63±5.23 g/dL.
There was no statistically significant difference in PLT 
count, RBC count, HB level, MCV, MCH, and MCHC of the 
pregnant women with their gestation age (P.0.05). How-
ever, PLT count showed a decreasing trend with gestational 
age. With respect to HCT values, a statistically significant 
difference (P=0.033) was observed between different tri-
mesters, with the lowest value observed among the women 
in the first trimester of pregnancy.
Discussion
Clinical laboratory reference intervals are essential for 
accurate interpretation of laboratory results, and they guide 
patient care and treatment. Furthermore, some of these val-
ues, such as the CD4+ T-cell count, are used as surrogate 
Table 1 sociodemographic and behavioral characteristics of 
HIV1/2-negative pregnant women who visited the anc clinic of 
the University of gondar Hospital, nW ethiopia, 2015
Sociodemographic and 
behavioral characteristics
Number Percentage
age, years
#24 72 36
25–33 111 55.5
34–42 17 8.5
Marital status
Married 199 99.5
single 1 0.5
educational status
Illiterate 37 18.5
Primary education 27 13.5
secondary education 82 41
Tertiary education 54 27
gestational age
First trimester 45 22.5
second trimester 69 34.5
Third trimester 86 43
gravidity
Primigravida 97 48.5
Multigravida 103 51.5
smoking habit
Yes 0 0
no 200 100
alcohol use
Yes 0 0
no 200 100
Abbreviations: anc, antenatal clinic; nW, northwest.
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markers for disease progression and/or in staging of diseases 
such as HIV infection. Even though hematological profiles 
of individuals reflect their general health, physiological 
conditions such as pregnancy are capable of causing remark-
able changes.9–11 Physiologic anemia, thrombocytopenia, 
and neutrophilia are some of the hematological changes 
reported during normal pregnancy. Despite these changes, 
many African countries, including Ethiopia, lack reference 
intervals specific to pregnant women and use reference 
intervals derived from the Western population in clinical 
practice. This necessitates the establishment of local refer-
ence intervals specific to healthy pregnant women. Such 
reference interval has paramount significance for the care 
and treatment of HIV-positive pregnant women as their 
number is increasing as a result of the universal access to 
ART. The current study describes the hematological and 
Table 2 Mean value, median, and 95% reference interval for immunological parameters among HIV-negative pregnant women who 
visited the anc of the University of gondar Hospital, nW ethiopia, 2015
Gestational age Absolute CD4 + T cell 
count/µL
CD4 + T cell 
count
Lymphocyte count, ×103/µL Total WBC count, ×103/µL
First trimester (n=45)
Mean ± sD 758±218 39.12±6.72 2.36±0.58* 9.46±2.80
Median 750 38.82 2.30 9.00
95% range 692.02–822.74 37.12–41.14 2.18–2.53 8.62–10.30
second trimester (n=69)
Mean ± sD 728±171 40.03±7.23 2.09±0.52* 9.29±2.56
Median 711 40.18 2.10 9.40
95% range 683.78–765.69 38.30–41.82 1.96–2.22 8.67–9.90
Third trimester (n=86)
Mean ± sD 735±148 39.34±6.58 2.21±0.50 9.10±2.36
Median 741 39.60 2.15 9.15
95% range 703.36–766.71 37.93–40.76 2.11–2.33 8.60–9.61
Total (n=200)
Mean ± sD 738±173 39.53±6.82 2.20±0.53 9.24±2.52
Median 738 39.57 2.20 9.05
95% range 712.47–760.67 38.58–40.49 2.13–2.28 8.90–9.60
P-value 0.09 0.19 0.97 0.07
Note: *P=0.033, post hoc test.
Abbreviations: anc, antenatal clinic; nW, northwest; sD, standard deviation; WBc, white blood cell.
Table 3 Mean value, median, and 95% reference interval for hematological parameters among HIV-negative pregnant women who 
visited the anc of the University of gondar Hospital, nW ethiopia, 2015
Gestational age Platelet count, ×103/µL RBC count, ×106/µL HB, g/dL Hematocrit, % MCV, fL MCH, pg MCHC, g/dL
First trimester (n=45)
Mean ± sD 243.87±64.38 4.27±0.62 12.94±1.70 39.18±6.70* 93.18±3.87 30.48±2.20 32.70±2.27
Median 255.00 4.29 13.00 40.30 93.40 30.20 32.30
95% range 224.53–253.21 4.08–4.46 12.43–13.46 37.17–41.19 92.02–94.34 29.82–31.14 37.02–33.38
second trimester (n=69)
Mean ± sD 230.78±71.09 4.32±0.46 13.07±1.05 40.53±3.77 94.19±4.21 30.47±2.64 33.29±8.55
Median 230.00 4.33 13.00 40.80 93.90 30.40 32.10
95% range 213.70–247.86 4.21–4.43 12.82–13.33 39.63–41.44 93.18–95.20 29.84–31.11 31.24–35.35
Third trimester (n=86)
Mean ± sD 223.74±66.42 4.46±0.43 13.38±1.25 41.96±3.70* 94.23±5.30 30.21±2.33 32.08±1.53
Median 224.00 4.42 13.45 41.70 93.95 30.00 32.00
95% range 209.50–237.38 4.37–4.55 13.11–13.67 41.17–42.75 93.09–95.37 26.73–40.79 31.75–32.41
Total (n=200)
Mean ± sD 230.70±67.74 4.37±0.49 13.2±1.3 40.8±4.7 93.98±4.64 30.36±2.41 32.63±5.23
Median 230.00 4.36 13.2 40.9 93.7 30.2 32
95% range 221.25–240.14 4.30–4.44 12.99–13.36 40.19–41.49 93.33–94.63 28.88–34.81 31.91–33.37
Note: *P=0.03 as determined by anOVa.
Abbreviations: anc, antenatal clinic; anOVa, analysis of variance; HB, hemoglobin; McH, mean corpuscular hemoglobin; McHc, mean corpuscular hemoglobin 
concentration; McV, mean cell volume; nW, northwest; rBc, red blood cell; sD, standard deviation.
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immunological reference intervals among HIV-seronega-
tive pregnant women in Northwest Ethiopia, where HIV 
prevalence is higher than 10%, albeit the low national HIV 
prevalence rate (1.14%).12–14
In this study, a decline in the number of CD4+ T-cell 
count was observed as pregnancy advances. This reduction 
in CD4+ T-cell count could be associated with the increase in 
hormones such as progesterone and estrogen, which suppress 
the maternal immune system to avoid rejection of the fetus. 
This finding was in agreement with the results of a number of 
previous studies.15,16 Moreover, the reference interval found in 
this study for absolute CD+ T-cell count (712.47–760.67) was 
within the range in other studies from Ethiopia (456–1,368), 
Mozambique (434–1,479), and Kenya (440–1,602) (range 
is an estimate of the 95% confidence limits).7,17,18 The mean 
WBC count observed in this study was higher than that in the 
study by Miri-Dashe et al15 among Nigerian pregnant women 
(9.24 vs 6.62). Similarly, the 95% interval of the WBC count 
among Ethiopian pregnant women was higher than that of 
Nigerian pregnant women. But, it was within the range of 
the US-based reference value.19 This finding supports the 
hypothesis that genetic factors could determine individuals’ 
CD4+ count. However, factors such as study design, presence 
of specific infection, and general nutritional status might also 
contribute to such discrepancies.
RBCs, HB, and HCT values were slightly higher in 
our study than in the US-based comparison intervals, pos-
sibly because of the higher altitude and dietary factors in 
Ethiopia.19 But, these were lower than the values in healthy, 
HIV-uninfected Ethiopian population.7 This is ascribed to 
the transient changes in the hematological profile of the 
women due to pregnancy. Similar findings have previously 
been observed in terms of a reduction in the RBC indexes 
among pregnant women.15 While the mean values for MCV 
and MCH in this study were higher than those of a similar 
study from Nigeria,15 the MCHC value was considerably 
lower than that of their Nigerian counterparts (32.63±5.23 
vs 36.45±1.10). Taken together, these findings underscore 
the need for establishing local reference intervals specific to 
the population under study for routine clinical practice.
Thrombocytopenia, defined as a PLT count ,150,000×109/L, 
is one of the common hematological ab normalities during 
pregnancy. This study showed that the PLT count among 
the study participants was within the normal range, despite a 
progressive reduction in PLT count as pregnancy advanced. 
This was in agreement with previously published studies.20,21 
PLT count has been reported to decrease by up to 10% in 
normal pregnancy, with most of the decrease occurring during 
the third trimester due to hemodilution resulting from an 
increase in plasma volume.
This study has some limitations in that we could not 
include pregnant women with no iron supplementation as a 
control group because of issues related to ethics. Furthermore, 
the majority of our study participants were highlanders from 
Gondar area, and they were predominantly from the Amhara 
ethnic group. Thus, the findings of this study may not apply 
to other ethnic groups who specially dwell in the lowland 
areas. Nevertheless, the reference intervals established in this 
study provide useful information for health care personnel 
and researchers in this specific area.
Conclusion
The laboratory reference intervals established by this study 
are one of the comprehensive immunohematological refer-
ence intervals specific to pregnant women in Northwest 
Ethiopia. The findings of this study highlight the differences 
in immunohematological profiles among pregnant women 
and nonpregnant women from Ethiopia and across countries 
and suggest the need for such establishment of local reference 
values for different populations.
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